acetaminophen 500 MG / phenyltoloxamine citrate 29 MG Oral Tablet [Relagesic]
RxNorm concept 1602570, branded drug (sbd). Prescribable name: Relagesic 500 MG / 29 MG Oral Tablet.
- RxCUI
- 1602570
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1602570 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
APAP 500 MG / Phenyltoloxamine citrate 29 MG Oral Tablet [Relagesic]; Relagesic (acetaminophen 500 MG / phenyltoloxamine citrate 29 MG) Oral Tablet
Related concepts
- acetaminophen 500 MG (SCDC, consists of)
- phenyltoloxamine citrate 29 MG (SCDC, consists of)
- acetaminophen 500 MG / phenyltoloxamine citrate 29 MG [Relagesic] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Relagesic (BN, has ingredient)
- acetaminophen 500 MG / phenyltoloxamine citrate 29 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 11584047703
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1602570 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1602570 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1602570. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.